Exploring treatment options in cancer: tumor treatment strategies

B Liu, H Zhou, L Tan, KTH Siu, XY Guan - Signal transduction and …, 2024 - nature.com
Traditional therapeutic approaches such as chemotherapy and radiation therapy have
burdened cancer patients with onerous physical and psychological challenges …

Biodegradable polyester-based nano drug delivery system in cancer chemotherapy: a review of recent progress (2021–2023)

Z Wang, M Xiao, F Guo, Y Yan, H Tian… - … in Bioengineering and …, 2023 - frontiersin.org
Cancer presents a formidable threat to human health, with the majority of cases currently
lacking a complete cure. Frequently, chemotherapy drugs are required to impede its …

Synergistic anticancer therapy via ferroptosis using modified bovine serum albumin nanoparticles loaded with sorafenib and simvastatin

K Kuche, V Yadav, M Dharshini, R Ghadi… - International Journal of …, 2023 - Elsevier
Ferroptosis is a non-apoptotic cell death pathway characterized by the accumulation of lipid-
peroxy radicals within the affected cells. Here, we investigate the synergistic capacity of …

Recent advances in degradable biomedical polymers for prevention, diagnosis and treatment of diseases

S Zhang, H Fang, H Tian - Biomacromolecules, 2024 - ACS Publications
Biomedical polymers play a key role in preventing, diagnosing, and treating diseases,
showcasing a wide range of applications. Their unique advantages, such as rich source …

Recent advances of multifunctional PLGA nanocarriers in the management of triple-negative breast cancer

YH Dinakar, N Rajana, NU Kumari, V Jain… - AAPS PharmSciTech, 2023 - Springer
Even though chemotherapy stands as a standard option in the therapy of TNBC, problems
associated with it such as anemia, bone marrow suppression, immune suppression, toxic …

Weibull β value for the discernment of drug release mechanism of PLGA particles

U de Jesús Martín-Camacho… - International Journal of …, 2023 - Elsevier
Mathematical models are used to characterize and optimize drug release in drug delivery
systems (DDS). One of the most widely used DDS is the poly (lactic-co-glycolic acid)(PLGA) …

Unlocking apoptosis in triple negative breast cancer: Harnessing “glutamine trap” to amplify the efficacy of lapatinib-loaded mixed micelles

R Ghadi, K Kuche, T Date, B Nallamothu… - Biomaterials …, 2024 - Elsevier
Certain aggressive cancers, such as triple-negative breast cancer (TNBC), heavily bank on
glutamine for their proliferation and survival. In this context, TNBC functions as a “glutamine …

Exploring Sorafenib and Simvastatin Combination for Ferroptosis-Induced Cancer Treatment: Cytotoxicity Screening, InVivo Efficacy, and Safety Assessment

K Kuche, V Yadav, M Patel, R Ghadi, S Jain - AAPS PharmSciTech, 2023 - Springer
Ferroptosis, a pathway dependent on oxygen and iron catalysts, holds promise as a
therapeutic approach for cancer treatment due to its manageable regulation, direct control …

Polymeric nanoparticles as a promising platform for treating triple-negative breast cancer: Current status and future perspectives

MA Bazzazan, P Fathollazadeh, SK Shahbaz… - International Journal of …, 2024 - Elsevier
Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that
lacks expression of estrogen, progesterone, and HER2 receptor targets for therapy …

Enhancing anti-cancer potential by delivering synergistic drug combinations via phenylboronic acid modified PLGA nanoparticles through ferroptosis-based therapy

K Kuche, V Yadav, M Patel, D Chaudhari, T Date… - Biomaterials …, 2024 - Elsevier
In this study, we investigated the potential of the sorafenib (SOR) and simvastatin (SIM)
combination to induce ferroptosis-mediated cancer therapy. To enhance targeted drug …